Vertex Ventures China
Vertex Ventures China is an early-stage venture capital firm investing in China's high-growth innovative technology and biomedicine startups, backed by Temasek Holdings and operating within the global Vertex Ventures network.
- Company typePrivate
- Founded2009
- HeadquartersBeijing, China
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Vertex Ventures China does
Vertex Ventures China is the China-focused early-stage venture capital arm of Singapore-based Vertex Ventures, itself backed by sovereign wealth fund Temasek Holdings. Founded in 2009 and headquartered in Beijing with additional offices in Shanghai, Shenzhen, and Singapore, the firm manages approximately RMB 20 billion in combined assets across multiple USD and RMB funds. Vertex China invests in high-growth innovative enterprises in mainland China across two primary verticals: innovative technology (robotics, AI, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, and commercial aerospace) and biomedicine (including medical devices). The firm has built a portfolio of 115+ companies, including 20+ unicorns, with 16 successful exits such as Mobike (acquired by Meituan), AnHeart (acquired by Nuvation Bio), and public listings including Horizon Robotics (9660.HK), Geek+ (2590.HK), Harbour BioMed (02142.HK), and SES AI (NYSE: SES).
The firm's core "product" is capital and value-added services delivered to early-stage founders, packaged with access to the broader Vertex global network spanning Israel, Japan, Southeast Asia, India, and the US. Revenue is generated through traditional VC economics — management fees on committed capital (typically 2%) and carried interest on profitable exits (typically 20% above hurdle rates) — with the dual-currency fund structure providing deployment flexibility across regulatory environments. Deal sourcing is network-driven, leveraging the Vertex global network, the Temasek ecosystem, portfolio company referrals, and participation in industry conferences such as the 36Kr WAVES New Wave 2025 Conference. The founding team has maintained 15+ years of continuity, with Managing Partners Tay Chee Chong and Xia Zhijin leading investment strategy, supported by Executive Partner Li Wei and Partner Yuan Jianwei.
Vertex China's competitive positioning rests on three structural advantages: the Temasek sovereign backing providing institutional credibility and co-investment capacity, the global Vertex network offering cross-border expansion pathways for portfolio companies, and a senior team with deep sector relationships built over more than a decade in China's VC ecosystem. The firm's recent activity — including the angel round lead in PureblueAI (an AI marketing technology company) in 2026 alongside co-investors 36Kr, Inno Fund, and Yicun Songling — signals continued active deployment and selective expansion into applied AI investment themes.
Vertex Ventures China firmographics
Firmographics- Name
- Vertex Ventures China
- Legal name
- Vertex Ventures China
- Website
- https://vertexventures.cn
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vertex Ventures China is an early-stage venture capital firm investing in China's high-growth innovative technology and biomedicine startups, backed by Temasek Holdings and operating within the global Vertex Ventures network.
- Ownership category
- akta.pro rank
Vertex Ventures China industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Vertex Ventures China is headquartered
LocationHeadquarters
- HQ city
- Beijing
- HQ country
- China
- HQ region
- Asia
Offices4 records
Markets served
Vertex Ventures China business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Distribution channels1 record
Marketing channels3 records
Vertex Ventures China product offering
Product offeringCore offering
Vertex Ventures China (祥峰中国) is an early-stage venture capital firm that deploys capital from multiple USD and RMB funds into high-growth technology and biomedicine startups across mainland China. The firm invests across sectors including robotics, artificial intelligence, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, biomedicine, medical devices, and commercial aerospace, and complements capital with value-added services and access to the broader Vertex global network. Vertex China operates as part of the Vertex Ventures network backed by Temasek Holdings of Singapore.
Product overview
Vertex Ventures China (祥峰投资) is a venture capital firm backed by Temasek Holdings of Singapore. It does not offer technology products or services to external customers. The firm operates multiple US dollar and RMB funds with combined assets under management of approximately RMB 20 billion (200亿元), focusing on early-stage investments in innovative technology and biomedicine sectors. Its core activities include identifying, funding, and supporting high-growth startups in robotics, artificial intelligence, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, biomedicine, medical devices, and commercial aerospace.
Differentiator
Problem solved
Functional benefit
Products and services
- USD Venture Capital Funds USD-denominated early-stage venture capital funds that deploy equity into high-growth Chinese startups in robotics, AI, semiconductor chips, advanced manufacturing, biomedicine, medical devices, and other innovation sectors. The funds are targeted at institutional and accredited limited partners seeking exposure to China's early-stage innovation economy.
- RMB Venture Capital Funds RMB-denominated early-stage venture capital funds that deploy equity into high-growth Chinese startups, enabling the firm to invest across different market conditions and accommodate domestic Chinese limited partners. Combined with the USD funds, total AUM is approximately RMB 20 billion.
Companies that use Vertex Ventures China
Customer profileSegments2 records
Ideal customer profiles2 records
Vertex Ventures China technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Vertex Ventures China partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights4 records
Vertex Ventures China competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Vertex Ventures China social profiles
Digital presenceVertex Ventures China financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vertex Ventures China leadership team
Management profileNumber of profiles
Profiles6 records
Vertex Ventures China funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vertex Ventures China M&A and investment
M&A and investmentM&A
Investments204 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vertex Ventures China
What does Vertex Ventures China do?
Vertex Ventures China (祥峰中国) is an early-stage venture capital firm that deploys capital from multiple USD and RMB funds into high-growth technology and biomedicine startups across mainland China. The firm invests across sectors including robotics, artificial intelligence, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, biomedicine, medical devices, and commercial aerospace, and complements capital with value-added services and access to the broader Vertex global network. Vertex China operates as part of the Vertex Ventures network backed by Temasek Holdings of Singapore.
Is Vertex Ventures China a public or private company?
Vertex Ventures China is a private company. It is classified as corporate owned and is currently operating.
When was Vertex Ventures China founded?
Vertex Ventures China was founded in 2009. It employs 11 to 50 people.
Where is Vertex Ventures China based?
Vertex Ventures China is headquartered in Beijing, China, in the Asia region.
Does Vertex Ventures China have an API?
No public API is recorded for Vertex Ventures China.
What industry is Vertex Ventures China in?
Vertex Ventures China's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.